protect
equip
mask
power
air
purifi
respir
papr
worn
interact
anim
prevent
accident
exposur
infect
staff
anim
social
hous
sex
group
whenev
possibl
fig
b
mani
standard
rabbit
cage
system
use
hous
ferret
experi
fig
space
grid
wall
food
receptacl
may
adapt
prevent
escap
hide
place
tube
tunnel
hammock
nest
box
provid
ball
valu
pathogenesi
studi
virus
requir
high
contain
differ
individu
ventil
cage
ivc
system
also
develop
adult
femal
ferret
weigh
g
male
weigh
g
thu
allow
repeat
blood
sampl
volum
suffici
immunolog
analys
cours
infect
bixler
elli
small
blood
sampl
obtain
tail
leg
vein
larger
volum
requir
isol
peripher
blood
mononuclear
cell
best
collect
anterior
vena
cava
fig
b
intern
jugular
vein
fig
sexual
weight
dimorph
togeth
requir
induc
ovul
femal
ferret
estru
led
mani
research
preferenti
use
male
fox
sherril
gorham
follow
fortuit
discoveri
natur
suscept
ferret
human
influenza
virus
smith
et
al
found
reproduc
human
cours
diseas
number
human
respiratori
virus
includ
respiratori
syncyti
viru
rsv
parainfluenzavirus
piv
sever
acut
respiratori
syndrom
sar
coronaviru
fig
addit
presenc
respect
receptor
fact
anatom
proport
ferret
upper
lower
respiratori
tract
densiti
submucos
gland
bronchial
wall
number
gener
termin
bronchiol
reproduc
situat
human
respiratori
tract
like
contribut
effect
johnsondelaney
orosz
robinson
et
al
technic
develop
enabl
infect
via
ocular
rout
aerosol
impact
inocul
rout
volum
pathogenesi
increasingli
recogn
belser
et
al
bodew
et
al
kreijtz
et
al
moor
et
al
studi
howev
anim
inocul
intranas
volum
rang
ml
context
infecti
diseas
research
ferret
wide
known
model
studi
influenza
virus
belong
orthomyxovirida
famili
pales
shaw
influenza
lesser
extent
influenza
b
virus
caus
annual
epidem
estim
death
worldwid
human
natur
reservoir
influenza
b
influenza
infect
broad
rang
avian
mammalian
speci
aquat
bird
act
princip
reservoir
among
livestock
infect
poultri
pig
greatest
econom
impact
hors
recent
dog
also
affect
avian
swine
influenza
virus
particular
public
health
relev
close
contact
human
provid
multipl
opportun
interspeci
adapt
transmiss
pales
shaw
influenza
virus
group
differ
subtyp
accord
antigen
surfac
glycoprotein
princip
target
neutral
antibodi
respons
gerhard
pales
shaw
far
hemagglutinin
ha
neuraminidas
na
subtyp
identifi
tong
et
al
tong
et
al
introduct
new
influenza
subtyp
human
popul
result
pandem
increas
morbid
mortal
johnson
mueller
avian
influenza
virus
classifi
low
pathogen
lpaiv
highli
pathogen
avian
influenza
virus
hpaiv
accord
ha
cleavag
site
lpaiv
carri
monobas
cleavag
site
activ
proteas
present
avian
respiratori
tract
hpaiv
activ
subtilisinlik
proteas
present
everi
cell
due
polybas
cleavag
site
bertram
et
al
ferret
becam
anim
model
choic
influenza
research
first
isol
influenza
viru
succeed
speci
smith
et
al
made
remark
contribut
understand
influenza
biolog
ever
sinc
addit
natur
suscept
human
influenza
strain
clinic
cours
diseas
ferret
reproduc
key
aspect
human
diseas
includ
fever
lethargi
sign
upper
sometim
lower
respiratori
infect
bouvier
lowen
smith
sweet
similar
influenza
receptor
distribut
human
ferret
respiratori
system
like
repres
import
contribut
factor
upper
respiratori
tract
speci
high
densiti
alpha
sialic
acid
well
alpha
sialic
acid
present
lower
respiratori
tract
shinya
et
al
van
riel
et
al
seen
adult
human
patient
uncompl
influenza
infect
ferret
season
strain
preferenti
bind
result
mild
moder
diseas
character
extens
infect
upper
respiratori
tract
limit
spread
lung
huang
et
al
van
den
brand
et
al
contrast
highli
pathogen
influenza
virus
higher
affin
alway
associ
sever
pneumonia
widespread
infect
throughout
lung
kumlin
et
al
nichol
et
al
shinya
et
al
van
riel
et
al
case
certain
strain
also
lead
neurolog
gastrointestin
involv
gambotto
et
al
assess
reconstruct
pandem
viru
ferret
demonstr
high
virul
histor
viru
compar
season
human
strain
taubenberg
et
al
tumpey
et
al
also
reveal
two
amino
acid
chang
ha
protein
suffici
switch
receptor
specif
abolish
respiratori
droplet
transmiss
tumpey
et
al
illustr
import
role
receptor
specif
influenza
pathogenesi
similar
influenza
suscept
human
ferret
increasingli
exploit
gain
insight
transmiss
virul
new
isol
humanadapt
season
influenza
virus
spread
direct
indirect
contact
respiratori
droplet
brankston
et
al
infect
avian
virus
usual
associ
close
contact
infect
poultri
rare
transmit
transmiss
assess
differ
hpai
ferret
confirm
poor
transmiss
observ
field
main
et
al
howev
great
concern
one
virus
acquir
capac
aerosol
spread
caus
pandem
matrosovich
et
al
steven
et
al
character
transmiss
determin
use
genet
modifi
virus
reveal
five
amino
acid
chang
ha
protein
suffici
enabl
effici
respiratori
droplet
transmiss
ferret
herfst
et
al
imai
et
al
linster
et
al
mutat
alreadi
describ
play
import
role
influenza
virul
ferret
mice
either
affect
replic
effici
alter
viru
tropism
chen
et
al
hatta
et
al
main
et
al
shinya
et
al
contrast
hpai
recent
emerg
human
isol
display
natur
affin
receptor
even
though
replic
effici
upper
lower
respiratori
tract
human
ferret
transmiss
studi
far
yield
contradictori
result
rang
report
effici
airborn
transmiss
reduc
aerosol
transmiss
compar
season
pandem
strain
contact
transmiss
belser
et
al
richard
et
al
valu
ferret
model
rapidli
gaug
virul
newli
emerg
viru
first
becam
appar
pandem
evalu
earli
isol
indic
increas
morbid
higher
pathogen
compar
season
strain
similar
transmiss
effici
main
et
al
munster
et
al
therebi
provid
valuabl
inform
public
health
offici
larg
bodi
work
investig
pathogenesi
transmiss
hpai
strain
isol
human
case
poultri
provid
framework
pandem
risk
assess
new
virus
emerg
anim
reservoir
kimbl
et
al
lipatov
et
al
main
et
al
sutton
et
al
yen
et
al
recent
avian
influenza
virus
isol
seal
found
natur
acquir
mutat
known
increas
transmiss
demonstr
increas
affin
mammalian
receptor
transmit
via
respiratori
droplet
ferret
karlsson
et
al
suggest
pandem
potenti
virus
year
novel
highli
pathogen
viru
isol
outbreak
poultri
first
korea
china
recent
also
europ
canada
fan
et
al
ku
et
al
wu
et
al
viru
caus
moder
sever
diseas
ferret
far
aviantohuman
transmiss
observ
continu
emerg
new
influenza
strain
bird
mammal
requir
activ
surveil
also
need
systemat
character
pandem
potenti
includ
pathogenesi
studi
ferret
despit
limit
avail
ferretspecif
immunolog
reagent
investig
innat
host
respons
base
mrna
express
level
either
quantit
realtim
rtpcr
use
canin
microarray
reveal
profil
similar
seen
patient
therebi
illustr
valu
anim
model
virul
assess
also
character
host
respons
kang
et
al
main
et
al
meunier
et
al
season
influenza
strain
gener
associ
rapid
rise
fall
type
ii
interferon
first
day
infect
svitek
et
al
highli
pathogen
strain
lead
sustain
express
interferon
respons
gene
higher
express
level
cytokin
inflammatori
mediat
lung
sinc
hypercytokinemia
cytokin
storm
also
observ
patient
de
jong
et
al
peiri
et
al
et
al
detail
character
underli
pathomechan
ferret
use
newli
develop
tool
assay
includ
detail
kinet
lymphocyt
subset
hematolog
paramet
serum
chemistri
profil
may
yield
innov
therapeut
approach
ferret
model
also
remain
gold
standard
efficaci
assess
new
vaccin
strategi
therapeut
approach
studi
usual
perform
use
seroneg
anim
elimin
addit
confound
factor
even
though
reflect
epidemiolog
situat
human
popul
adult
expos
least
one
like
sever
strain
circul
subtyp
fonvil
et
al
hoschler
et
al
time
inactiv
influenza
vaccin
liveattenu
influenza
vaccin
laiv
licens
countri
lambert
fauci
laiv
induc
stronger
immun
respons
individu
inactiv
vaccin
immunogen
presenc
preexist
immun
context
annual
vaccin
campaign
laiv
thu
primarili
given
children
young
adult
rodger
et
al
potenti
laiv
induc
broader
effici
immun
respons
newli
emerg
strain
investig
extens
studi
ferret
demonstr
recombin
laiv
elicit
broad
crossprotect
differ
sublineag
li
et
al
suguitan
et
al
recent
shown
immun
laiv
result
cross
protect
newli
emerg
viru
xu
et
al
immunogen
extent
crossprotect
also
investig
inactiv
pandem
vaccin
gener
wholeviru
inactiv
vaccin
induc
robust
respons
singl
dose
may
even
protect
antigenet
mismatch
virus
govorkova
et
al
poland
sambhara
subbarao
luke
contrast
splitviru
subunit
vaccin
less
immunogen
one
dose
addit
adjuv
requir
protect
individu
bresson
et
al
de
groot
et
al
duan
et
al
lin
et
al
develop
safe
efficaci
adjuv
great
relev
context
pandem
prepared
sinc
use
adjuv
reduc
amount
antigen
need
per
dose
clegg
et
al
onishi
et
al
addit
develop
adjuv
season
vaccin
consid
senior
often
respond
poorli
current
use
nonadjuv
inactiv
vaccin
ann
et
al
van
den
brand
et
al
comprehens
overview
innov
vaccin
approach
influenza
beyond
scope
review
among
promis
candid
viruslik
particl
vlp
compos
matrix
protein
togeth
ha
na
protein
intranas
intramuscular
vaccin
vlp
contain
protein
protein
alon
induc
immun
respons
present
protect
ferret
challeng
multipl
avian
influenza
virus
mahmood
et
al
pushko
et
al
ross
et
al
tretyakova
et
al
differ
viral
vectorbas
approach
also
develop
clinic
trial
stage
among
recombin
modifi
vaccinia
viru
ankara
mva
express
differ
ha
subtyp
demonstr
efficaci
ferret
recent
firstinman
clinic
trial
confirm
immunogen
human
kreijtz
et
al
kreijtz
et
al
rimmelzwaan
sutter
dnaand
recent
rnabas
vaccin
candid
great
appeal
pandem
context
sinc
produc
rapidli
larg
scale
dna
vaccin
express
singl
multipl
ha
protein
alon
combin
na
induc
protect
b
cell
respons
differ
anim
model
especi
context
primeboost
regimen
vaccin
candid
bragstad
et
al
lin
et
al
pillet
et
al
rao
et
al
suguitan
et
al
first
proofofconcept
studi
rna
vaccin
induc
immun
respons
similar
approv
influenza
vaccin
ferret
pig
petsch
et
al
indic
feasibl
approach
howev
despit
recent
progress
use
vivo
electropor
gene
gun
laddi
et
al
yager
et
al
effici
dna
rna
deliveri
remain
major
obstacl
implement
technolog
time
two
class
commerci
avail
drug
influenza
adamantanederiv
inhibit
ion
channel
neuraminidas
inhibitor
addit
viral
polymeras
inhibitor
favipiravir
receiv
regulatori
approv
japan
use
influenza
furuta
et
al
nagata
et
al
earli
ferret
studi
demonstr
rapid
emerg
antivir
resist
adamantan
transmiss
drugresist
strain
without
loss
virul
herloch
et
al
sweet
et
al
therebi
predict
today
resist
circul
season
influenza
strain
bright
et
al
bright
et
al
nonetheless
adamantan
may
still
use
context
pandem
strain
carri
nonresist
segment
anim
origin
nguyen
et
al
ferret
studi
also
demonstr
efficaci
neuraminidas
inhibitor
lethal
infect
differ
strain
boltz
et
al
boltz
et
al
govorkova
et
al
integr
part
pandem
prepared
strategi
emerg
oseltamivirresist
strain
studi
ferret
use
character
impact
mutat
involv
investig
fit
cost
associ
resist
watanab
et
al
ferret
studi
thu
remain
integr
part
develop
new
prophylact
therapeut
strategi
influenza
henipavirus
hendra
hev
nipah
niv
virus
belong
genu
henipaviru
within
paramyxovirida
famili
natur
host
fruit
bat
famili
pteropodida
found
southeast
asia
australia
africa
hayman
et
al
olson
et
al
young
et
al
infect
bat
shed
viru
urin
therebi
infect
speci
transmiss
human
occur
intermedi
host
like
pig
niv
hors
hev
lubi
et
al
ephrin
identifi
cellular
receptor
henipavirus
highli
conserv
present
endotheli
cell
smooth
muscl
cell
neuron
gale
et
al
thu
thought
contribut
broad
speci
tissu
tropism
bonapart
et
al
human
henipaviru
case
fatal
rate
approxim
diseas
start
influenzalik
symptom
fever
dri
cough
sore
throat
lymphadenopathi
often
lead
acut
respiratori
distress
symptom
ard
hossain
et
al
high
incid
neurolog
symptom
survivor
often
experi
neurolog
sequela
month
even
year
acut
infect
osullivan
et
al
playford
et
al
tan
et
al
wong
et
al
ferret
experiment
infect
niv
hev
develop
full
spectrum
diseas
seen
human
first
clinic
sign
occur
day
infect
start
fever
cough
nasal
discharg
short
breath
depress
sometim
follow
limb
paralysi
mening
bossart
et
al
pallist
et
al
pallist
et
al
comparison
niv
strain
isol
patient
bangladesh
malaysia
reveal
differ
amount
viru
shed
oral
secret
infect
ferret
may
explain
increas
humantohuman
transmiss
seen
outbreak
bangladesh
clayton
et
al
howev
extens
pathogenesi
transmiss
studi
limit
high
contain
requir
work
virus
recent
gener
recombin
hev
express
gfp
luciferas
addit
open
read
frame
retain
abil
caus
fatal
diseas
ferret
thu
constitut
valuabl
tool
directli
character
dissemin
visual
virushost
interact
marsh
et
al
current
vaccin
antivir
treatment
approv
human
hev
vaccin
hors
base
solubl
hev
glycoprotein
avail
sinc
efficaci
studi
ferret
instrument
develop
vaccin
middleton
et
al
pallist
et
al
analog
approach
niv
protect
ferret
niv
challeng
month
pallist
et
al
vesicular
stomat
viru
pseudotyp
niv
glycoprotein
equal
protect
ferret
indic
develop
effici
safe
vaccin
virus
feasibl
mire
et
al
addit
potenti
monoclon
antibodi
treatment
also
demonstr
ferret
use
monoclon
antibodi
block
receptorbind
domain
hev
niv
g
glycoprotein
bossart
et
al
valid
ferret
anim
model
virus
human
respiratori
syncyti
viru
hrsv
human
metapneumoviru
hmpv
belong
pneumovirina
subfamili
paramyxovirida
famili
one
lead
caus
respiratori
diseas
children
worldwid
year
affect
million
children
age
five
well
elderli
individu
preexist
respiratori
condit
falsey
et
al
nair
et
al
van
den
hoogen
et
al
virus
transmit
via
respiratori
droplet
direct
contact
respiratori
secret
hall
et
al
infect
limit
respiratori
epitheli
cell
lotz
peebl
diseas
mostli
character
cough
sneez
fever
howev
newborn
especi
prematur
born
infant
progress
apnea
feed
difficulti
period
breath
collin
graham
dahlem
et
al
van
den
hoogen
et
al
elderli
patient
infect
often
lead
pneumonia
chronic
pulmonari
diseas
asthma
congest
heart
failur
falsey
et
al
falsey
et
al
current
vaccin
hrsv
hmpv
approv
antivir
drug
ribavirin
human
monoclon
antibodi
direct
rsv
f
glycoprotein
johnson
et
al
ferret
suscept
hrsv
hmpv
infect
virus
replic
high
titer
nasal
tissu
coat
chanock
howev
hmpvinfect
ferret
show
sign
diseas
macphail
et
al
anim
infect
earli
life
hrsv
caus
acut
chronic
chang
neural
control
airway
persist
long
viru
clear
colasurdo
et
al
larsen
colasurdo
ferret
also
use
investig
potenti
recombin
adenovirus
express
rsv
fusion
attach
glycoprotein
individu
combin
intranas
administr
strong
rsvspecif
antibodi
respons
observ
anim
protect
subsequ
rsv
challeng
hsu
et
al
sinc
replic
lung
take
place
infant
ferret
princ
porter
use
anim
model
pneumoviru
pathogenesi
studi
limit
littl
known
cellular
receptor
mechan
involv
even
though
ferret
reproduc
agedepend
differ
diseas
sever
seen
human
ferret
suscept
measl
viru
mev
member
morbilliviru
genu
infect
human
certain
nonhuman
primat
howev
sensit
canin
distemp
viru
cdv
infect
broad
rang
terrestri
aquat
carnivor
diseas
reproduc
key
element
seen
mevinfect
patient
ludlow
et
al
high
degre
genet
structur
function
conserv
among
morbillivirus
consist
cours
diseas
caus
cdv
ferret
model
frequent
use
character
common
morbilliviru
pathogenesi
mechan
upon
infect
cdv
wild
type
strain
via
respiratori
rout
viru
first
isol
peripher
blood
mononuclear
cell
pbmc
day
b
lymphocyt
lymphat
organ
cdvposit
within
one
week
pillet
von
messl
coincid
dramat
drop
white
blood
cell
number
loss
pbmc
prolifer
activ
upon
nonspecif
stimul
von
messl
et
al
decreas
white
blood
cell
seen
infect
extent
inhibit
pbmc
prolifer
activ
innat
immun
activ
correl
diseas
sever
svitek
von
messl
latter
control
accessori
v
protein
ramachandran
et
al
rothlisberg
et
al
recent
studi
ferret
reveal
inhibit
signal
essenti
morbillivirusmedi
interfer
innat
immun
respons
svitek
et
al
signal
lymphocyt
activ
molecul
slam
identifi
morbilliviru
immun
cell
receptor
tatsuo
et
al
tatsuo
et
al
pathogenesi
studi
slamblind
virus
first
cdv
ferret
mev
macaqu
reveal
immun
cell
infect
essenti
immunosuppress
clinic
diseas
therebi
confirm
immun
cell
first
hypothesi
leonard
et
al
von
messl
et
al
amplif
lymphat
organ
viru
spread
epitheli
tissu
throughout
bodi
immun
respons
suffici
control
subsequ
clear
viru
loss
epitheli
integr
eventu
lead
septicemia
death
within
three
five
week
infect
recent
identifi
epitheli
cell
receptor
muhlebach
et
al
noyc
et
al
enabl
gener
virus
subsequ
illustr
import
epitheli
cell
infect
clinic
diseas
also
demonstr
acut
immunosuppress
requir
immun
epitheli
cell
infect
frenzk
et
al
sawatski
et
al
sinc
incid
neuroinvas
ferret
reach
strain
also
use
investig
morbilliviru
neuropathogenesi
mechan
addit
previous
known
entri
rout
via
choroid
plexu
small
blood
vessel
anterograd
infect
along
olfactori
nerv
identifi
addit
entri
pathway
rudd
et
al
compar
studi
differ
strain
reveal
correl
longer
diseas
durat
less
sever
immunosuppress
bonami
et
al
studi
cdv
ferret
surrog
mev
primat
also
use
investig
potenti
novel
vaccin
recent
antivir
drug
candid
krumm
et
al
rouxel
et
al
welter
et
al
consist
pathogenesi
togeth
avail
robust
revers
genet
system
sever
vaccin
wild
type
strain
thu
make
cdvferret
model
attract
system
character
virushost
interact
context
lethal
diseas
outcom
surviv
investig
impact
intervent
differ
stage
diseas
addit
virus
caus
mild
upper
respiratori
tract
infect
coronavirina
subfamili
also
includ
member
lead
sever
acut
respiratori
diseas
mortal
rate
around
sever
acut
respiratori
syndrom
sar
cov
even
higher
middl
east
respiratori
syndrom
mer
cov
butler
hui
et
al
respiratori
tropism
suscept
ferret
evalu
case
sarscov
viru
found
replic
effici
upper
lower
respiratori
tract
anim
develop
clinic
diseas
character
nasal
discharg
sneez
fever
viru
shed
includ
contact
transmiss
cage
mate
intratrach
infect
chu
et
al
martina
et
al
howev
clinic
sign
seen
intranas
infect
differ
studi
weingartl
et
al
variabl
may
due
rout
infect
age
gender
genet
anim
like
addit
contribut
factor
human
sarscov
tropism
reflect
distribut
cellular
receptor
angiotensinconvert
enzym
ace
drosten
et
al
li
et
al
lung
alveolar
epitheli
cell
enterocyt
small
intestin
tubular
cell
kidney
ding
et
al
gu
et
al
ham
et
al
diseas
rang
mild
respiratori
sign
sever
respiratori
failur
incub
period
day
patient
initi
present
influenzalik
symptom
fever
cough
progress
atyp
pneumonia
respiratori
failur
viru
also
spread
multipl
organ
includ
gastrointestin
urinari
tract
caus
system
diseas
even
though
shown
ferret
interact
effici
sarscov
receptorbind
spike
protein
zamoto
et
al
tropism
sarscov
ferret
match
receptor
distribut
gramberg
et
al
may
explain
differ
clinic
manifest
observ
nevertheless
ferret
repres
use
anim
model
safeti
efficaci
assess
sarscov
vaccin
candid
therapeut
approach
mvabas
vaccin
express
sarscov
protein
elicit
strong
neutral
immun
respons
protect
anim
diseas
inflammatori
lesion
found
liver
vaccin
anim
weingartl
et
al
formalininactiv
wholeviru
vaccin
well
sexpress
adenovirusbas
vaccin
also
induc
neutral
antibodi
liver
patholog
note
extent
protect
vari
indic
combin
vaccin
strategi
may
requir
effect
protect
darnel
et
al
see
et
al
prophylact
treatment
monoclon
antibodi
reduc
replic
sarscov
lung
infect
ferret
one
thousandfold
may
thu
use
protect
contact
therebi
limit
spread
diseas
ter
meulen
et
al
case
merscov
also
caus
sever
pulmonari
diseas
human
similar
sarscov
zaki
et
al
ferret
found
suscept
even
though
merscov
sarscov
member
genu
betacoronaviru
differ
receptor
usag
merscov
use
dipeptidyl
peptidas
dpp
cell
entri
raj
et
al
also
found
ferret
cell
sequenc
differ
human
ferret
protein
prevent
bind
merscov
van
doremalen
et
al
explain
lack
infect
speci
even
though
rabi
pathogenesi
mostli
studi
dog
raccoon
fox
protect
efficaci
commerci
inactiv
rabi
vaccin
also
demonstr
ferret
rupprecht
et
al
context
pathogenesi
studi
experiment
infect
ferret
assess
suscept
incub
period
morbid
clinic
sign
seroconvers
viru
shed
interestingli
ferret
surviv
infect
rabi
viru
isol
one
anim
niezgoda
et
al
surviv
ferret
experiment
infect
rabi
viru
also
report
differ
studi
hamir
et
al
indic
might
resist
carnivor
ferret
also
use
character
newli
discov
lyssavirus
zoonot
potenti
evalu
efficaci
crossprotect
avail
rabi
vaccin
hanlon
et
al
vo
et
al
potenti
ferret
anim
model
evalu
viral
diseas
includ
mump
viru
simian
viru
canin
human
parainfluenza
virus
rubella
viru
two
recent
studi
demonstr
mump
virusinfect
ferret
mount
robust
humor
cellular
immun
respons
develop
clinic
sign
viru
shed
indic
use
model
limit
parker
et
al
xu
et
al
ferret
infect
simian
viru
canin
human
parainfluenza
virus
gener
caus
mild
transient
diseas
natur
host
develop
antibodi
respons
histopatholog
chang
indic
infect
upper
respiratori
tract
similar
seen
speci
may
thu
attract
model
develop
vaccin
antivir
capraro
et
al
durchfeld
et
al
mascoli
et
al
mascoli
et
al
final
late
sixti
use
ferret
anim
model
neonat
rubella
explor
ultim
unsuccess
elizan
et
al
fabiyi
et
al
rork
et
al
ferret
use
anim
model
viral
research
sinc
begin
centuri
start
influenza
suscept
human
respiratori
virus
becam
increasingli
appar
follow
ever
increas
number
addit
pathogen
tabl
even
though
hous
requir
elabor
rodent
ferret
still
accommod
anim
facil
anim
purchas
sever
commerci
sourc
greatest
disadvantag
ferret
anim
model
remain
rel
lack
speciesspecif
reagent
although
intern
effort
made
improv
situat
gener
ferretspecif
tool
identifi
crossreact
reagent
rutigliano
et
al
ferret
immun
respons
still
poorli
character
addit
potenti
model
character
contribut
opportunist
infect
differ
rout
inocul
dynam
aerosol
transmiss
infect
context
immunosuppress
comorbid
begin
explor
belser
et
al
gustin
et
al
huber
mcculler
koster
et
al
mcculler
et
al
peltola
et
al
great
public
health
relev
studi
date
focus
influenza
virus
extens
pathogen
like
follow
near
futur
complet
ferret
genom
public
ferret
transcriptom
bruder
et
al
peng
et
al
also
open
new
avenu
experiment
possibl
identifi
transcrib
mrna
activ
gene
given
time
point
viral
infect
ferret
genom
inform
also
facilit
develop
speciesspecif
genom
proteom
tool
map
signal
pathway
succeed
somat
cell
nuclear
transfer
cftrknockout
ferret
cystic
fibrosi
model
sun
et
al
provid
proofofconcept
gener
transgen
anim
specif
phenotyp
technic
advanc
transgen
field
use
sleep
beauti
transposon
ivic
et
al
crisprca
system
hai
et
al
tang
et
al
put
transgen
ferret
within
reach
infecti
diseas
research
commun
new
virus
continu
emerg
addit
immunolog
genom
proteom
tool
ferret
becom
avail
import
anim
model
infecti
diseas
research
like
continu
increas
